In addition, hyperammonemia may also lead to calcium overload by activating NMDA receptors, promote pathological tau protein hyperphosphorylation, and contribute to Alzheimer’s disease-like changes (Rodrigo et al., 2010), ultimately resulting in neurocognitive dysfunction. This evidence concerns the gene MAPT and Alzheimer disease.